Return
Psoriasis at high-impact sites: shifting the paradigm
DOI:10.1093/bjd/ljaf404.png)
Abstract
En
Keywords:
MONOCLONAL-ANTIBODY
PLAQUE PSORIASIS
DOUBLE-BLIND
EFFICACY
MODERATE
SAFETY
USTEKINUMAB
PHASE-3
Journal
IF:
9.6
Papers:
2.8W
Citations:
3.2W

